WBIW News

Brought to you by WBIW News and Network Indiana

1340 AM, Sunday, September 7th, 2008
Make WBIW.com Your Home Page

USDA Investigating Drug Sedation Symptoms

Last updated on Friday, February 29, 2008
Advertisement

(INDIANAPOLIS) - The U.S. Food and Drug Administration is delaying approval of a longer-lasting version of Eli Lilly’s top-selling drug Zyprexa.

Regulators want to learn more about why some patients experienced symptoms described as excessive sedation.

Some patients wind up in a coma-like state for hours after taking the drug. Others were drowsy or had slurred speech.


Section navigation: Previous Article  |  Next Article  (Archives)

When you see news happening, tell us!
Call 812.275.7555  |  E-mail tips@wbiw.com  |  Or send an IM via your AOL, MSN or Yahoo Messenger to wbiwnews